126 related articles for article (PubMed ID: 37532567)
1. Comparison of Flavonoid and Flavonoid Glycoside in the Inhibition of the Starch Hydrolyzing Enzymes and AGEs; A Virtual Approaches.
Sadeghi M; Miroliaei M; Rahimmalek M; Taslimi P; Szumny A; Sadeghian N
J Oleo Sci; 2023; 72(8):787-797. PubMed ID: 37532567
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of flavonoid glycosides on digestive enzymes: In silico, in vitro, and in vivo studies.
Sadeghi M; Miroliaei M; Ghanadian M
Int J Biol Macromol; 2022 Sep; 217():714-730. PubMed ID: 35843397
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of inhibition of advanced glycation end-products (AGEs) and α-glucosidase by Heliotropium bacciferum: Spectroscopic and molecular docking analysis.
Al-Bagmi MS; Alokail MS; Alenad AM; Alnaami AM; Abuelgassim AO; Khan MS
Int J Biol Macromol; 2024 May; 268(Pt 2):131609. PubMed ID: 38621555
[TBL] [Abstract][Full Text] [Related]
4. Galangin inhibits α-glucosidase activity and formation of non-enzymatic glycation products.
Zeng L; Ding H; Hu X; Zhang G; Gong D
Food Chem; 2019 Jan; 271():70-79. PubMed ID: 30236734
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory mechanism of sinensetin on α-glucosidase and non-enzymatic glycation: Insights from spectroscopy and molecular docking analyses.
Liu D; Cao X; Kong Y; Mu T; Liu J
Int J Biol Macromol; 2021 Jan; 166():259-267. PubMed ID: 33115652
[TBL] [Abstract][Full Text] [Related]
6. Flavonoids as potential agents in the management of type 2 diabetes through the modulation of α-amylase and α-glucosidase activity: a review.
Proença C; Ribeiro D; Freitas M; Fernandes E
Crit Rev Food Sci Nutr; 2022; 62(12):3137-3207. PubMed ID: 33427491
[TBL] [Abstract][Full Text] [Related]
7. Trifluoromethylated Flavonoid-Based Isoxazoles as Antidiabetic and Anti-Obesity Agents: Synthesis, In Vitro
Algethami FK; Saidi I; Abdelhamid HN; Elamin MR; Abdulkhair BY; Chrouda A; Ben Jannet H
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500647
[TBL] [Abstract][Full Text] [Related]
8. Feruloyl Sucrose Esters: Potent and Selective Inhibitors of α-glucosidase and α-amylase.
Devaraj S; Yip YM; Panda P; Ong LL; Wong PWK; Zhang D; Ali Y; Judeh Z
Curr Med Chem; 2022; 29(9):1606-1621. PubMed ID: 34455958
[TBL] [Abstract][Full Text] [Related]
9. Flavonoids and proanthocyanidins-rich fractions from Eugenia dysenterica fruits and leaves inhibit the formation of advanced glycation end-products and the activities of α-amylase and α-glucosidase.
Justino AB; Guerra Silva HC; Franco RR; de Oliveira Cavalcante Pimentel I; Silva NF; Saraiva AL; Espindola FS
J Ethnopharmacol; 2022 Mar; 285():114902. PubMed ID: 34890729
[TBL] [Abstract][Full Text] [Related]
10. In Silico Approaches to Identify Polyphenol Compounds as α-Glucosidase and α-Amylase Inhibitors against Type-II Diabetes.
Riyaphan J; Pham DC; Leong MK; Weng CF
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944521
[TBL] [Abstract][Full Text] [Related]
11. Target guided isolation, in-vitro antidiabetic, antioxidant activity and molecular docking studies of some flavonoids from Albizzia Lebbeck Benth. bark.
Ahmed D; Kumar V; Sharma M; Verma A
BMC Complement Altern Med; 2014 May; 14():155. PubMed ID: 24886138
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of saccharides and phenolic compounds from maize silks on intestinal α-glucosidases.
Alvarado-Díaz CS; Gutiérrez-Méndez N; Mendoza-López ML; Rodríguez-Rodríguez MZ; Quintero-Ramos A; Landeros-Martínez LL; Rodríguez-Valdez LM; Rodríguez-Figueroa JC; Pérez-Vega S; Salmeron-Ochoa I; Leal-Ramos MY
J Food Biochem; 2019 Jul; 43(7):e12896. PubMed ID: 31353692
[TBL] [Abstract][Full Text] [Related]
13. Anti-diabetic potential of Masclura tricuspidata leaves: Prenylated isoflavonoids with α-glucosidase inhibitory and anti-glycation activity.
Jo YH; Lee S; Yeon SW; Turk A; Lee JH; Hong SM; Han YK; Lee KY; Hwang BY; Kim SY; Lee MK
Bioorg Chem; 2021 Sep; 114():105098. PubMed ID: 34153812
[TBL] [Abstract][Full Text] [Related]
14. Isolated compounds from Dracaena angustifolia Roxb and acarbose synergistically/additively inhibit α-glucosidase and α-amylase: an in vitro study.
Yi J; Zhao T; Zhang Y; Tan Y; Han X; Tang Y; Chen G
BMC Complement Med Ther; 2022 Jul; 22(1):177. PubMed ID: 35780093
[TBL] [Abstract][Full Text] [Related]
15. α-Glucosidase inhibition by flavonoids: an in vitro and in silico structure-activity relationship study.
Proença C; Freitas M; Ribeiro D; Oliveira EFT; Sousa JLC; Tomé SM; Ramos MJ; Silva AMS; Fernandes PA; Fernandes E
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1216-1228. PubMed ID: 28933564
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory Effects of Siegesbeckia orientalis Extracts on Advanced Glycation End Product Formation and Key Enzymes Related to Metabolic Syndrome.
Hung WC; Ling XH; Chang CC; Hsu HF; Wang SW; Lee YC; Luo C; Lee YT; Houng JY
Molecules; 2017 Oct; 22(10):. PubMed ID: 29065451
[TBL] [Abstract][Full Text] [Related]
17. In vitro inhibitory activities of selected Australian medicinal plant extracts against protein glycation, angiotensin converting enzyme (ACE) and digestive enzymes linked to type II diabetes.
Deo P; Hewawasam E; Karakoulakis A; Claudie DJ; Nelson R; Simpson BS; Smith NM; Semple SJ
BMC Complement Altern Med; 2016 Nov; 16(1):435. PubMed ID: 27809834
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in silico inhibition properties of fucoidan against α-amylase and α-D-glucosidase with relevance to type 2 diabetes mellitus.
S LS; Raghu C; H A A; P A
Carbohydr Polym; 2019 Apr; 209():350-355. PubMed ID: 30732817
[TBL] [Abstract][Full Text] [Related]
19. Molecular Docking and Dynamics Simulation of Natural Compounds from Betel Leaves (
Ahmed S; Ali MC; Ruma RA; Mahmud S; Paul GK; Saleh MA; Alshahrani MM; Obaidullah AJ; Biswas SK; Rahman MM; Rahman MM; Islam MR
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889399
[No Abstract] [Full Text] [Related]
20. Hesperetin-Cu(II) complex as potential α-amylase and α-glucosidase inhibitor: Inhibition mechanism and molecular docking.
Peng X; Liu K; Hu X; Gong D; Zhang G
Spectrochim Acta A Mol Biomol Spectrosc; 2023 Apr; 290():122301. PubMed ID: 36603279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
